-transparent.png){kind=logo}
Dimethindene maleate (DM) (= Fenistil) is a potent antihistamine with a prolonged duration of action. On the histamine-stimulated guinea-pig ileum DM has a pA2 of 9.3 but produces a very marked depression of the maximum response at 10(-8) M. DM has no effect on H2 receptors nor on H3 receptors, and is not a calcium channel blocker. Muscarinic receptors (carbachol-stimulated ileum) were only influenced (competitively) at 10(-7) M or above, suggesting that the non-competitive effects described above could be due to a specific reaction with the histamine H1 receptor. As non-specific effects, such as membrane-stabilisation, would normally be seen with both isomers equally, we studied the effects of the optical isomers of DM. The (-) isomer had a profile identical to that of DM, but was slightly more potent. The (+) isomer was some 30 times less potent (results confirmed by binding studies). However in contrast to DM and the (-) isomer, the (+) isomer showed a "classical" antagonism, pA2 = 7.7, with no evidence of non-competitive effects. Thus the more active (-) isomer of DM has a potent, non-competitive H1 histamine antagonist effect. The relevance of these findings to DM's clinical profile is discussed.
R Towart, and
M Sautel, and
E Moret, and
E Costa, and
M Theraulaz, and
A F Weitsch
September 1982,
Orvosi hetilap,
R Towart, and
M Sautel, and
E Moret, and
E Costa, and
M Theraulaz, and
A F Weitsch
April 1992,
Methods and findings in experimental and clinical pharmacology,
R Towart, and
M Sautel, and
E Moret, and
E Costa, and
M Theraulaz, and
A F Weitsch
January 1990,
Fundamental & clinical pharmacology,
R Towart, and
M Sautel, and
E Moret, and
E Costa, and
M Theraulaz, and
A F Weitsch
July 1984,
Acta pharmaceutica Hungarica,
R Towart, and
M Sautel, and
E Moret, and
E Costa, and
M Theraulaz, and
A F Weitsch
January 1959,
Acta physiologica Academiae Scientiarum Hungaricae,
R Towart, and
M Sautel, and
E Moret, and
E Costa, and
M Theraulaz, and
A F Weitsch
March 1962,
Praxis,
R Towart, and
M Sautel, and
E Moret, and
E Costa, and
M Theraulaz, and
A F Weitsch
April 2000,
Biological & pharmaceutical bulletin,
R Towart, and
M Sautel, and
E Moret, and
E Costa, and
M Theraulaz, and
A F Weitsch
April 1964,
Southern medical journal,
R Towart, and
M Sautel, and
E Moret, and
E Costa, and
M Theraulaz, and
A F Weitsch
October 1973,
Zeitschrift fur Hautkrankheiten,
R Towart, and
M Sautel, and
E Moret, and
E Costa, and
M Theraulaz, and
A F Weitsch
February 1987,
British journal of clinical pharmacology,
